- Home
- BWEN vs IPSC Comparison
BWEN vs IPSC Comparison
Compare BWEN & IPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWEN
- IPSC
- Stock Information
- Founded
- BWEN N/A
- IPSC 2019
- Country
- BWEN United States
- IPSC United States
- Employees
- BWEN N/A
- IPSC N/A
- Industry
- BWEN Industrial Machinery/Components
- IPSC Medicinal Chemicals and Botanical Products
- Sector
- BWEN Industrials
- IPSC Health Care
- Exchange
- BWEN Nasdaq
- IPSC Nasdaq
- Market Cap
- BWEN 43.0M
- IPSC 49.6M
- IPO Year
- BWEN N/A
- IPSC 2021
- Fundamental
- Price
- BWEN $1.88
- IPSC $0.56
- Analyst Decision
- BWEN Strong Buy
- IPSC Strong Buy
- Analyst Count
- BWEN 3
- IPSC 5
- Target Price
- BWEN $4.50
- IPSC $3.33
- AVG Volume (30 Days)
- BWEN 102.9K
- IPSC 942.0K
- Earning Date
- BWEN 08-12-2025
- IPSC 08-07-2025
- Dividend Yield
- BWEN N/A
- IPSC N/A
- EPS Growth
- BWEN N/A
- IPSC N/A
- EPS
- BWEN N/A
- IPSC N/A
- Revenue
- BWEN $142,358,000.00
- IPSC $114,898,000.00
- Revenue This Year
- BWEN $7.86
- IPSC $1,064.82
- Revenue Next Year
- BWEN $4.51
- IPSC N/A
- P/E Ratio
- BWEN N/A
- IPSC N/A
- Revenue Growth
- BWEN N/A
- IPSC 8286.72
- 52 Week Low
- BWEN $1.41
- IPSC $0.34
- 52 Week High
- BWEN $3.69
- IPSC $3.29
- Technical
- Relative Strength Index (RSI)
- BWEN 59.28
- IPSC 48.22
- Support Level
- BWEN $1.77
- IPSC $0.55
- Resistance Level
- BWEN $1.95
- IPSC $0.60
- Average True Range (ATR)
- BWEN 0.09
- IPSC 0.04
- MACD
- BWEN -0.00
- IPSC -0.00
- Stochastic Oscillator
- BWEN 65.38
- IPSC 15.96
About BWEN Broadwind Inc.
Broadwind Inc is a precision manufacturer of structures, equipment and components for clean technology and other specialized applications. The company provide technologically high value products to customers with complex systems and stringent quality standards that operate in energy, mining and infrastructure sectors, in the United States of America. It capabilities include heavy fabrications, welding, metal rolling, coatings, gear cutting and shaping, gearbox manufacturing and repair, heat treat, assembly, engineering and packaging solutions. It operates through four operating segments namely Heavy Fabrications, Gearing, Industrial Solutions and Corporate.
About IPSC Century Therapeutics Inc.
Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.